104.08
104.08 (0%)
As of Feb 14, 2025
GILEAD SCIENCES [GILD]
Source:
Company Overview
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
| Country | United States |
| Headquarters | foster city, california |
| Phone Number | (650) 574-3000 |
| Industry | manufacturing |
| CEO | Daniel P. O’Day |
| Website | www.gilead.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $28,754 |
| Operating Profit | $1,662 |
| Net Income | $480 |
| Net Cash | $3,906 |
Profit Ratios
| Gross Margin | $22,503 |
| Operating Margin | 5.8 |
| Profit as % of Revenues | 4,688.1% |
| Profit as % of Assets | 0.8% |
| Profit as % of Stockholder Equity | 2.5% |
Management Effectiveness
| Return on Equity | 2.5% |
| Return on Assets | 0.8% |
| Turnover Ratio | 47.5% |
| EBITA | $1,662 |
Balance Sheet and Cash Flow Measures
| Total Assets | $58,995 |
| Total Liabilities | $39,749 |
| Operating Cash Flow | $10,828 |
| Investing Cash Flow | $-3,449 |
| Financing Cash Flow | $-3,433 |
